Home | BioBucks

Latest Editions of BioBucks

Oct 13, 2026

Tuesday: BMS's 60mg IPF win comes with a 120mg asterisk

Plus a first-in-class herpes approval, an alpha-emitter Phase 3 win, and three biotechs queuing for IPOs.

Oct 9, 2026

Friday: Viatris pays $1.65B for Pacira's pain cash flows

Oct 8, 2026

Thursday: argenx's $2.2B celiac bet pays off as Vyvgart misses

Oct 7, 2026

Wednesday: Forbion banks €2.3B

Oct 6, 2026

Tuesday: Vaxcyte rips, while $2B rare-disease M&A lands

Oct 5, 2026

Monday: CSL writes a $355M check for Alentis' kidney bet

Oct 2, 2026

Friday: Novartis drops $575M on Abogen's mRNA engager

Oct 1, 2026

Thursday: Sanofi hands Regeneron $1B to find the next Dupixent

Sep 30, 2026

Wednesday: uniQure's 41% gap-down and Lilly's triple-G encore

Sep 29, 2026

Tuesday: Kodiak's Eylea match and AstraZeneca's $2B Summit stake